Key driver of aggressive prostate cancer identified, suggesting new way to reverse drug resistance - Medical Xpress
MedicalxpressOctober 7, 2026
Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more aggressive, drug-resistant form of the disease.
Where this sits on TrendsMap
This story hasn’t been tied to a specific state or province yet — it sits in our United States coverage. We hold 1047 health stories in total, and 29 from Medicalxpress.
This is a summary of reporting by Medicalxpress. Read the full story at the source.
Read full storyPredictions (0)
No predictions yet on this story — be the first to start one.
Comments (0)
GU
posting as a guest
Create a free account to comment under your own name and earn Pulse.